Sangamo Biosciences, Inc. (SGMO) Tops Q4 EPS by 5c, Guides FY Rev

February 6, 2013 4:10 PM EST Send to a Friend
Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q4 EPS of ($0.07), $0.05 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $8.9 million versus the consensus estimate of $5.95 million.

Sangamo Biosciences, Inc. sees FY2013 revenue of $20-24 million, versus the consensus of $23.09 million.

For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment